News & Alerts
-
Mar- 2024 -18 March
The US FDA Rejects Viatris’s Injection for Multiple Sclerosis
The U.S. Food and Drug Administration (FDA) has declined to approve Viatris and Mapi Pharma’s once-a-month injection intended for treating…
Read More » -
18 March
Madrigal Pharma Shares Surges After Drug Wins First Approval For Fatty Liver Disease NASH
Madrigal Pharmaceuticals (MDGL.O) experienced a significant surge in its stock value, jumping by as much as 23% on Friday, following…
Read More » -
18 March
AstraZeneca to buy Amolyt Pharma for $1.05 Billion to Boost Rare-Disease Portfolio
Drugmaker AstraZeneca announced on Thursday its intention to acquire Amolyt Pharma, a company specializing in endocrine diseases, for a hefty…
Read More » -
18 March
How Healthcare Organisations Hire Physicians
(Image Source) Whether in hospitals, clinics, or laboratories, physicians play an indispensable role in providing high-quality treatment in healthcare organizations.…
Read More » -
15 March
Israel’s Gynica Starts Clinical Trial for Endometriosis Cure
Israeli biotechnology firm Gynica has embarked on an innovative journey towards developing a potential cure for endometriosis, a condition affecting…
Read More » -
15 March
Pandorum Technologies Secures USD 11 Million Investment to Advance Regenerative Therapy for Corneal Blindness
Pandorum Technologies, a leading biotechnology company specializing in tissue engineering and regenerative medicine, has announced the successful closure of a…
Read More » -
15 March
Biotheus Inc. and Hansoh Pharma Expand Strategic Collaboration for Cancer Treatment Advancements
Biotheus Inc. (Biotheus), a prominent clinical-stage biotech company specializing in biologics for oncology and inflammatory diseases, and Hansoh Pharmaceutical Group…
Read More » -
15 March
Global 3D Cell Cultures Market Set to Reach $14.8 Billion by 2028
BCC Research, a leading market research firm, has projected significant growth for the global 3D cell cultures market, estimating it…
Read More » -
13 March
Par Pharmaceutical Issues Recall for Treprostinil Injection Due to Silicone Particulates
Par Pharmaceutical, Inc. (Par), a subsidiary of Endo International plc based in Dublin, Ireland, has issued a voluntary nationwide recall…
Read More » -
7 March
Novo Market Valuation Surpasses Tesla on Experimental Obesity Drug Data
Novo Nordisk, has achieved a significant milestone by surpassing Tesla Inc. in market valuation following the promising results of its…
Read More »